Cardiol Therapeutics Inc. (TSX: CRDL)
CRDL trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Close · October 14, 2026
C$1.60
-6.43% on the day
Market cap (C$)
C$281.9M
TMX list, September 30, 2026
Market cap (US$)
US$197.6M
Micro cap at 1.4263 C$/US$
1-year return
+9.6%
+22.1% year to date
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for CRDL.TO, last bar 2026-10-14, computed by Sophia Capital.
Profile
| Field | Value |
|---|---|
| Ticker | CRDL on the Toronto Stock Exchange |
| Yahoo symbol | CRDL.TO |
| Sector | Life Sciences, Cannabis |
| Headquarters | Ontario |
| Listed | 2018-12-20 |
| Listing type | IPO |
| Shares outstanding | 118,930,414 |
| Also listed on | NasdaqCM |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001702123 |
| Website | No company website on record |
| US listing | CRDL |
Returns
| Window | Return |
|---|---|
| 1 day | -6.4% |
| 1 week | -14.9% |
| 1 month | -42.2% |
| 3 months | -1.8% |
| 6 months | -16.7% |
| Year to date | +22.1% |
| 1 year | +9.6% |
| From 52-week high | -49.4% |
| 52-week range | C$1.28 to C$3.16 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
119 documents in 12 types. Each title links to the document at its source.
Annual financial statements (2)
| Document | Type | Filed |
|---|---|---|
| Audited Financial Statements of the Registrant for the year ended December 31, 2025, together with the Auditors’ Report thereon Period 2025-12-31 | Annual financial statements (40-F) | 2026-03-31 |
| Audited Financial Statements of the Registrant for the year ended December 31, 2024, together with the Auditors’ Report thereon Period 2024-12-31 | Annual financial statements (40-F) | 2025-03-31 |
Interim financial statements (6)
| Document | Type | Filed |
|---|---|---|
| Condensed Interim Consolidated Financial Statements | Interim financial statements (6-K) | 2026-08-12 |
| Condensed Interim Period 2026-03-31 | Interim financial statements (6-K) | 2026-05-11 |
| Condensed Interim Period 2025-09-30 | Interim financial statements (6-K) | 2025-11-13 |
| Condensed Interim Period 2025-06-30 | Interim financial statements (6-K) | 2025-08-14 |
MD&A (7)
| Document | Type | Filed |
|---|---|---|
| Management’s Discussion and Analysis of the Registrant for the year ended December 31, 2025 Period 2025-12-31 | MD&A (annual) (40-F) | 2026-03-31 |
| Management’s Discussion and Analysis of the Registrant for the year ended December 31, 2024 Period 2024-12-31 | MD&A (annual) (40-F) | 2025-03-31 |
| Management’s Discussion and Analysis Three and | MD&A (interim) (6-K) | 2026-08-12 |
| Management’s Period 2026-03-31 | MD&A (interim) (6-K) | 2026-05-11 |
Annual information form (2)
| Document | Type | Filed |
|---|---|---|
| Annual Information Form of the Registrant for the year ended December 31, 2025 Period 2025-12-31 | Annual information form (40-F) | 2026-03-31 |
| Annual Information Form of the Registrant for the year ended December 31, 2024 Period 2024-12-31 | Annual information form (40-F) | 2025-03-31 |
Material change report (2)
| Document | Type | Filed |
|---|---|---|
| Material Change Report dated January 26, 2026 | Material change report (6-K) | 2026-01-26 |
| Material Change Report dated October 27, 2025 | Material change report (6-K) | 2025-10-27 |
News release (37)
| Document | Type | Filed |
|---|---|---|
| NEWS RELEASE DATED SEPTEMBER 23, 2026 | News release (6-K) | 2026-09-23 |
| NEWS RELEASE DATED SEPTEMBER 16, 2026 | News release (6-K) | 2026-09-16 |
| NEWS RELEASE DATED SEPTEMBER 10, 2026 | News release (6-K) | 2026-09-10 |
| NEWS RELEASE DATED SEPTEMBER 9, 2026 | News release (6-K) | 2026-09-09 |
Management information circular / proxy (8)
| Document | Type | Filed |
|---|---|---|
| Management Information Circular | Management information circular (6-K) | 2026-05-26 |
| Management Period 2024-12-31 | Management information circular (6-K) | 2025-04-28 |
| Notice of Annual General Meeting of Shareholders | Notice of meeting (6-K) | 2026-05-26 |
| Notice of Meeting and Record Date, dated April 10, 2026 | Notice of meeting (6-K) | 2026-04-10 |
Prospectus (5)
| Document | Type | Filed |
|---|---|---|
| F-10/A | Prospectus (short form) (F-10/A) | 2026-09-16 |
| F-10 | Prospectus (short form) (F-10) | 2026-09-10 |
| FORM F-10 | Prospectus (short form) (F-10) | 2025-11-05 |
| SUPPL | Prospectus supplement (SUPPL) | 2026-09-16 |
Annual report (2)
| Document | Type | Filed |
|---|---|---|
| 40-F Period 2025-12-31 | Annual report (40-F) (40-F) | 2026-03-31 |
| 40-F Period 2024-12-31 | Annual report (40-F) (40-F) | 2025-03-31 |
Early warning / ownership (6)
| Document | Type | Filed |
|---|---|---|
| Schedule 13G amendment | Schedule 13G (SCHEDULE 13G/A) | 2026-09-23 |
| Schedule 13G amendment | Schedule 13G (SCHEDULE 13G/A) | 2026-08-14 |
| Schedule 13G amendment | Schedule 13G (SCHEDULE 13G/A) | 2026-05-15 |
| Schedule 13G | Schedule 13G (SCHEDULE 13G) | 2026-01-30 |
Certification (20)
| Document | Type | Filed |
|---|---|---|
| Form 52-109F2 Certification | Certification (52-109F2) (6-K) | 2026-08-12 |
| Form 52-109F2 Certification | Certification (52-109F2) (6-K) | 2026-08-12 |
| Form 52-109F2 Certification of Interim Filings - CEO | Certification (52-109F2) (6-K) | 2026-05-11 |
| Form 52-109F2 Certification of Interim Filings - CFO | Certification (52-109F2) (6-K) | 2026-05-11 |
Other (22)
| Document | Type | Filed |
|---|---|---|
| EXHIBIT 5.1 | Consent (F-10/A) | 2026-09-16 |
| EXHIBIT 5.1 | Consent (F-10) | 2026-09-10 |
| Consent of Independent Registered Public Accounting Firm – BDO Canada LLP (PCAOB ID#01227) Period 2025-12-31 | Consent (40-F) | 2026-03-31 |
| EXHIBIT 5.1 | Consent (F-10) | 2025-11-05 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
Trading: the last notice, on 2026-01-16, was a resumption.
| Notice | Action | Reason | Notice |
|---|---|---|---|
| 2026-01-16 9:00 AM ET | Resumption | No reason stated | CIRO notice |
| 2026-01-16 8:10 AM ET | Halt | Pending News | CIRO notice |
| 2025-10-20 8:00 AM ET | Resumption | No reason stated | CIRO notice |
| 2025-10-17 4:12 PM ET | Halt | Pending News | CIRO notice |
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2025-11-04 | Equity, Option To Acquire, Security To Be Acquired, Other | US$760K | US$8.5M | SEC EDGAR |
| 2020-12-15 | Equity, Option To Acquire, Security To Be Acquired, Other | US$829K | US$9.1M | SEC EDGAR |
| 2019-01-04 | Equity, Option To Acquire, Security To Be Acquired, Other | US$3.7M | US$8.4M | SEC EDGAR |
| 2017-09-29 | Equity | US$680K | US$680K | SEC EDGAR |
| 2017-03-29 | Equity | US$56K | US$56K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| PAIN | Vector Science and Therapeutics Corp. | TSXV | C$300.3M | -18.4% | Under a year of closes |
| PRN | Profound Medical Corp. | TSX | C$304.9M | +17.1% | +17.5% |
| MSCL | Satellos Bioscience Inc. | TSX | C$256.5M | -29.7% | -1.0% |
| AIDX | HealWELL AI Inc. | TSX | C$243.8M | -11.7% | -51.8% |
| EDT | Spectral Medical Inc. | TSX | C$335.9M | -14.0% | -20.7% |
The app has the price chart, every filing, private raises and the full peer set for CRDL.
Open in the app